Oncolytics Biotech launches $75M at-the-market equity offering to fund pelareorep trials
Filed April 6, 2026 · Period ending April 6, 2026 · ~1 min read
3 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade ONCY commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 3, 2026 7:13 PM